BamSEC and AlphaSense Join Forces
Learn More

Fate Therapeutics Inc.

NASDAQ: FATE    
Share price (12/20/24): $1.68    
Market cap (12/20/24): $191 million

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Fate Therapeutics, Inc
12/34/56
EX-3
from 8-K 3 pages Certificate of Amendment to Fate Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Class a Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Fate Therapeutics, Inc
12/34/56
EX-3.3
from 10-K 15 pages Amended and Restated Bylaws of Fate Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 2 to the Amended and Restated Bylaws of Fate Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Amended and Restated Bylaws of Fate Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 21 pages Fate Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Class a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Class a Convertible Preferred Stock
12/34/56
EX-3.5
from S-1/A 3 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Fate Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 22 pages Amended and Restated Bylaws of Fate Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 7 pages Amended and Restated Certificate of Incorporation of Fate Therapeutics, Inc
12/34/56
EX-3.3
from S-1 18 pages Bylaws of Fate Therapeutics, Inc. (A Delaware Corporation) Adopted as of April 27, 2007
12/34/56
EX-3.1
from S-1 21 pages Fate Therapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3
from DRS 18 pages Bylaws of Fate Therapeutics, Inc. (A Delaware Corporation) Adopted as of April 27, 2007
12/34/56
EX-3
from DRS 23 pages Fate Therapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56